Curran Terrie - Insider Non-Derivative Transactions at Phathom Pharmaceuticals, Inc. (PHAT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 15, 2024, Curran Terrie's relationship to Phathom Pharmaceuticals, Inc. (PHAT) is Director,Officer (President and Chief Executive), and currently has 377,734 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PHAT insiders.
Data Source: SEC.
Curran Terrie - Insider Non-Derivative Transactions of PHAT Common Stock
Curran Terrie - Insider Non-Derivative Transactions at PHAT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 16, 2024 | Sell -- (Common Stock) | 33848 | 11.72 | 377734 |
| Mar 23, 2024 | Sell -- (Common Stock) | 16851 | 9.11 | 410784 |
| Nov 2, 2023 | Acquisition -- (Common Stock) | 37500 | 0 | 427171 |
| Jul 15, 2023 | Acquisition -- (Common Stock) | 200000 | 0 | 389671 |
| Apr 7, 2023 | P -- (Common Stock) | 12919 | 7.82 | 188290 |
| Mar 2, 2023 | Sell -- (Common Stock) | 1436 | 8.54 | 175371 |
| Jan 21, 2023 | Sell -- (Common Stock) | 5821 | 8.2 | 176807 |
| Jan 20, 2023 | Acquisition -- (Common Stock) | 97500 | 0 | 182628 |